Melanie Proulx Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Lower Pln, Bradford, VT 05033 Phone: 802-222-9292 Fax: 802-222-5549 |
Peter E. Macgillivray, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Lower Pln, Bradford, VT 05033 Phone: 802-222-9292 Fax: 802-222-5549 |
Janeen Wernecke Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Lower Pln, Bradford, VT 05033 Phone: 802-222-9292 Fax: 802-222-5549 |
Travis Ryan Gross Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Lower Pln, Bradford, VT 05033 Phone: 802-222-9292 |
Katherine Frank Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Lower Pln, Bradford, VT 05033 Phone: 802-222-9292 |
Adam Luke Kuzmeskus, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 586 Lower Plains Rd, Bradford, VT 05033 Phone: 802-222-3374 |
Deborah Sleeper, BS PHARMACY Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Lower Pln, Bradford, VT 05033 Phone: 802-222-9292 Fax: 802-222-5549 |
News Archive
More than 1,100 Medicare prescription drug (Part D) plans are available for 2011. Most consumers have about 33 plans to choose from in their area during annual enrollment, which is Nov. 15 to Dec. 31. However, Part D plans with the lowest premiums may not be the best match for Medicare beneficiaries' individualized needs, according to Allsup, a nationwide provider of Social Security disability representation and Medicare plan selection services.
The state's Democratic and Republican lawmakers are embroiled in a game of chicken that threatens to blow up the Medicaid program, which serves 700,000 poor Mississipians. Meanwhile, reports from Indiana, Montana and California detail other developments related to state officials' decisions about whether to expand the program under the health law.
The treatment of childhood cancer is one of the great success stories of modern medicine. A few decades ago, only 20 percent of children survived the disease. Today, overall survival rates approach 80 percent. Yet cancer remains the leading cause of death from disease in U.S. children older than 1 year of age, and some types of pediatric cancer continue to have poor survival rates.
Like any successful team effort, the best qualities of two drugs commonly prescribed for enlarged prostate yielded better results than either of the medicines alone, according to a new study from UT Southwestern Medical Center.
A study presented at the 2016 Genitourinary Cancers Symposium shows that 40 percent of patients with castration-resistant metastatic prostate cancer (mCRPC) treated with docetaxel following abiraterone had at least 50 percent reduction in prostate specific antigen (PSA), demonstrating the activity of this drug sequencing.
› Verified 1 days ago